Non-immune thrombocytopenia responsive to antiretroviral therapy and HIV-2 infection

Journal of Infection

Volumn 54, Issue 1, 2007, Pages

  Torres, Jaime R ^a   Torres Viera, Maria A ^b   Schupbach, Jorg ^c   Rangel, Hector R ^d   Pujol, Flor H ^d  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b Municipal Blood Bank   (Venezuela)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

HIV 2 infection; Thrombocytopenia

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; PREDNISONE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; ZIDOVUDINE;

AGED; ANTIBODY DETECTION; ARTICLE; BONE MARROW EXAMINATION; CASE REPORT; CAUCASIAN; DRUG EFFICACY; DRUG RESPONSE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MALE; NUCLEOTIDE SEQUENCE; PHYSICAL EXAMINATION; T CELL LYMPHOMA; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VIRUS GENOME; VIRUS MUTATION; VIRUS RESISTANCE; VIRUS STRAIN; WESTERN BLOTTING;

AGED; ANTI-HIV AGENTS; FAMILY HEALTH; HETEROSEXUALITY; HIV INFECTIONS; HIV-2; HUMANS; LYMPHOMA; MALE; THROMBOCYTOPENIA; VENEZUELA;

EID: 33845662714     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2006.03.022     Document Type: Article

References (12)

1. UNAIDS 2004 report on the global AIDS epidemic (July 2004), UNAIDS/WHO, Geneva
2. Schim van der Loeff M.F., and Aaby P. Towards a better understanding of the epidemiology of HIV-2. AIDS 13 (1999) 69-84
3. Damond F., Worobey M., Campa P., Farfara I., Colin G., Matheron S., et al. Identification of a highly divergent HIV type 2 and proposal for a change in HIV type 2 classification. AIDS Res Hum Retroviruses 20 (2004) 666-672
4. Colson P., Henry M., Tourres C., Lozachmeur D., Gallais H., Gastaut J.A., et al. Polymorphism and drug-selected mutations in the protease gene of human immunodeficiency virus type 2 from patients living in Southern France. J Clin Microbiol 42 (2004) 570-607
5. + cell counts in HIV-1 infection. Eur J Haematol 61 (1998) 216-217
6. Glatt A.E., and Anand A. Thrombocytopenia in patients infected with human immunodeficiency virus: treatment update. Clin Infect Dis 21 (1995) 415-423
7. Colson P., Henry M., Tivoli N., Gallais H., Gastaut J.A., Moreau J., et al. Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France. J Med Virol 75 (2005) 381-390
8. Dominguez A., Gamallo G., Garcia R., Lopez-Pastor A., Pena J.M., and Vazquez J.J. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients. J Clin Pathol 47 (1994) 999-1003
9. Sato T., Sekine H., Kakuda H., Miura N., Sunohara M., and Fuse A. HIV infection of megakaryocytic cell lines. Leuk Lymphoma 36 (2000) 397-404
10. Louache F., Bettaieb A., Henri A., et al. Infection of megakaryocytes by human immunodeficiency virus in seropositive patients with immune thrombocytopenic purpura. Blood 78 (1991) 1697-1705
11. Sakaguchi M., Sato T., and Groopman J.E. Human immunodeficiency virus infection of megakaryocytic cells. Blood 77 (1991) 481-485
12. Caso J.A., Mingo C.S., and Tena J.G. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection. N Engl J Med 341 (1999) 1239-1240